Clover Health Investments, CORP /DE Form 4 insider transactions

Clover Health Investments Corp. director William G. Robinson Jr. was granted 79,365 restricted stock units, vesting in January 2027.

Clover Health director Thomas L. Tran was granted 79,365 Class A Common Stock shares through a restricted stock unit award, increasing his beneficial ownership to 180,029 shares.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, sold 2,102 shares of Class A Common Stock for $2.53 per share under a pre-arranged 10b5-1 trading plan.

Clover Health CEO Andrew Toy disposed of 267,958 Class A Common Stock shares on January 1, 2026, to cover tax liabilities from RSU vesting.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, disposed of 8,109 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Clover Health Investments Corp.'s CEO of Medicare Advantage, Jamie L. Reynoso, sold 4,913 shares of Class A Common Stock for a weighted average price of $2.61 per share.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, reported the automatic withholding of shares to cover tax obligations related to RSU vestings on December 14 and 15, 2025.

Clover Health's CEO, Conrad Wai, disposed of 98,411 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health's General Counsel, Karen Soares, disposed of 6,404 Class A Common Stock shares at $2.70 each to cover tax obligations related to RSU vesting.

Clover Health's General Counsel, Karen Soares, disposed of 7,459 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health CEO Andrew Toy disposed of 85,535 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, sold 30,385 shares of Class A Common Stock for a weighted average price of $3.58 per share.

Clover Health's CEO of Home Care, Brady Patrick Priest, disposed of Class A Common Stock shares on October 31, 2025, to cover tax obligations related to RSU vesting.

Clover Health's General Counsel, Karen Soares, had shares withheld to cover tax obligations upon the vesting of restricted stock units.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, reported the disposition of shares to cover tax obligations upon the vesting of restricted stock units.

Clover Health CEO Conrad Wai reported the disposal of Class A Common Stock to cover tax obligations related to the vesting of restricted stock units.

Clover Health's CFO, Peter J. Kuipers, disposed of 217,382 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health, sold 16,514 shares of Class A Common Stock for approximately $44,492 under a pre-arranged Rule 10b5-1 trading plan.

Clover Health's CEO of Home Care, Brady Patrick Priest, reported the automatic withholding of 48,305 shares to cover tax obligations from RSU vesting.

Clover Health Investments' CEO of Home Care, Brady Priest, had 82,778 shares withheld for tax obligations following an RSU vesting event.

Clover Health CEO Andrew Toy disposed of 242,580 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, disposed of 71,432 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Clover Health General Counsel Karen Soares reported the automatic withholding of 57,249 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Clover Health CEO Conrad Wai disposed of 92,181 Class A Common Stock shares at $2.8 each to cover tax obligations related to RSU vesting.

Jamie L. Reynoso, Clover Health's CEO of Medicare Advantage, reported the sale of 2,012 Class A Common Stock shares under a 10b5-1 plan and the withholding of 8,706 shares for tax obligations.

Clover Health CEO Andrew Toy disposed of 308,950 Class A Common Stock shares on October 1, 2025, to cover tax obligations related to RSU vesting.

Jamie L. Reynoso, Clover Health's CEO of Medicare Advantage, sold 4,914 shares of Class A Common Stock for $3.09 per share under a Rule 10b5-1 trading plan.

Clover Health's General Counsel, Karen Soares, had 6,403 shares withheld to cover tax obligations upon the vesting of restricted stock units.

Clover Health's CEO, Medicare Advantage, Jamie L. Reynoso, reported the disposition of Class A Common Stock for tax obligations related to RSU vesting.

Clover Health's CEO, Jamie L. Reynoso, filed an amended Form 4 to correct the reported number of shares withheld for tax obligations related to RSU vesting.